The New World of Type 1 Diabetes
Dr. Jeremy Pettus is an endocrinologist and associate clinical professor of medicine at the University of California, San Diego, and Director of Type 1 Diabetes Track at Taking Control of Your Diabetes (TCOYD).
Dr. Pettus acknowledged that while the “struggle is real” with T1D, there have also been a lot of very positive advancements in recent years that make life with T1D easier and healthier:
- T1D technology is booming. This means better diabetes control and less mental burden.
- There are newer insulins and new forms of glucagon that are more effective and easier to use.
- Other medications are now being explored to help improve blood glucose control.
- We have our first-ever approved drug, Tzield, to delay the onset of T1D.
Dr. Pettus is extremely optimistic about the future. “People with T1D are now living longer than people without diabetes because we’re so in tune with our health,” he said. “It really is an amazing day to have type 1 diabetes.”
Updates from Our CEO
JDRF CEO Aaron J. Kowalski, Ph.D., discussed the importance of research and advocacy in developing advanced therapies and cures for T1D.
Cell therapies and disease-modifying therapies are two of the most promising approaches to curing type 1 diabetes. JDRF has been supporting both for decades and there have been exciting advances recently:
But if you don’t have access to these therapies and treatments, you don’t benefit from the research. That’s where JDRF Advocacy comes into play. We’ve made some important wins recently:
But gaps to access remain. JDRF is working to ensure that all advances are available to all people with T1D, no matter who they are or where they live.
“Continue to use your powerful voices to drive change, to drive funding, to drive insulin affordability, to drive access, and to help us make cures a reality for the entire type 1 diabetes community,” Dr. Kowalski said.